Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism

Thrombosis Research

Volumn 121, Issue 6, 2008, Pages 793-797

  Brogren, Helén ^a   Wallmark, Karin ^a   Jern, Sverker ^a   Karlsson, Lena ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibrinolysis; mRNA; Plasminogen activator inhibitor 1; Platelets; Polymorphism

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ALLELE; ARTICLE; BODY MASS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; HOMOZYGOTE; HUMAN; MALE; NORMAL HUMAN; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLELES; BLOOD PLATELETS; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 41749084428     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.07.018     Document Type: Article

References (23)

1. Booth N.A., Simpson A.J., Croll A., Bennett B., and MacGregor I.R. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 70 3 (1988) 327-333
2. Potter van Loon B.J., Rijken D.C., Brommer E.J., and van der Maas A.P. The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility. Thromb Haemost 67 1 (1992) 101-105
3. Declerck P.J., Alessi M.C., Verstreken M., Kruithof E.K., Juhan-Vague I., and Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 71 1 (1988) 220-225
4. Booyse F.M., and Rafelson Jr. M.E. Stable messenger RNA in the synthesis of contractile protein in human platelets. Biochim Biophys Acta 145 1 (1967) 188-190
5. Booyse F., and Rafelson Jr. M.E. In vitro incorporation of amino-acids into the contractile protein of human blood platelets. Nature 215 98 (1967) 283-284
6. Gnatenko D.V., Dunn J.J., McCorkle S.R., Weissmann D., Perrotta P.L., and Bahou W.F. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101 6 (2003) 2285-2293
7. McRedmond J.P., Park S.D., Reilly D.F., Coppinger J.A., Maguire P.B., Shields D.C., et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 3 2 (2004) 133-144
8. Brogren H., Karlsson L., Andersson M., Wang L., Erlinge D., and Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 104 13 (2004) 3943-3948
9. Dawson S.J., Wiman B., Hamsten A., Green F., Humphries S., and Henney A.M. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268 15 (1993) 10739-10745
10. Eriksson P., Kallin B., van 't Hooft F.M., Bavenholm P., and Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92 6 (1995) 1851-1855
11. Juhan-Vague I., Morange P.E., Frere C., Aillaud M.F., Alessi M.C., Hawe E., et al. The plasminogen activator inhibitor-1-675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost 1 11 (2003) 2322-2329
12. Hong Y., Pedersen N.L., Egberg N., and de Faire U. Moderate genetic influences on plasma levels of plasminogen activator inhibitor-1 and evidence of genetic and environmental influences shared by plasminogen activator inhibitor-1, triglycerides, and body mass index. Arterioscler Thromb Vasc Biol 17 11 (1997) 2776-2782
13. de Lange M., Snieder H., Ariens R.A., Spector T.D., and Grant P.J. The genetics of haemostasis: a twin study. Lancet 357 9250 (2001) 101-105
14. Jeng J.R. Association of PAI-1 gene promoter 4G/5G polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension. Am J Hypertens 16 4 (2003) 290-296
15. Martinez-Calatrava M.J., Martinez-Larrad M.T., Zabena C., Gonzalez-Sanchez J.L., Fernandez-Perez C., and Serrano-Rios M. The 4G/4G PAI-1 genotype is associated with elevated plasma PAI-1 levels regardless of variables of the metabolic syndrome and smoking status. A population-based study in Spanish population. Diabetes Obes Metab 9 1 (2007) 134-135
16. Doggen C.J., Bertina R.M., Cats V.M., Reitsma P.H., and Rosendaal F.R. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 82 1 (1999) 115-120
17. Zietz B., Buechler C., Drobnik W., Herfarth H., Scholmerich J., and Schaffler A. Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels. Endocr Res 30 3 (2004) 443-453
18. Nordt T.K., Eschenfelder E., Peter K., Sobel B.E., and Bode C. Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G/5G polymorphism of the PAI-1 gene. Thromb Haemost 90 1 (2003) 36-42
19. Siegbahn A., Odlind V., Hedner U., and Venge P. Coagulation and fibrinolysis during the normal menstrual cycle. Ups J Med Sci 94 2 (1989) 137-152
20. van der Bom J.G., Bots M.L., Haverkate F., Kluft C., and Grobbee D.E. The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1. Blood 101 5 (2003) 1841-1844
21. Zhan M., Zhou Y., and Han Z.C. No association of the plasminogen activator inhibitor-1 promoter 4G/5G polymorphism with inhibitor level during basal transcription in vitro. Int J Hematol 79 4 (2004) 400-404
22. Wang L., Ostberg O., Wihlborg A.K., Brogren H., Jern S., and Erlinge D. Quantification of ADP and ATP receptor expression in human platelets. J Thromb Haemost 1 2 (2003) 330-336
23. Cigolini M., Targher G., Seidell J.C., Schiavon R., Manara F., Zenti M.G., et al. Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. Atherosclerosis 106 2 (1994) 139-147